JOURNEY AS AN ORTHOPAEDIC SURGEON, RESEARCHER, SURGICAL SITE INFECTION CONTROL & BONE LOSS EXPERT Associate Professor Kevin Tetsworth, Orthopaedic Surgeon
As an orthopaedic surgeon, Associate Professor Kevin Tetsworth, is widely recognised for his expertise in managing orthopaedic infections, chronic osteomyelitis, limb salvage, and reconstruction. He holds clinical appointments at the Royal Brisbane and Women’s Hospital, the Wesley Hospital in Brisbane, Macquarie University in Sydney at the Limb Reconstruction Centre.
His credentials encompass a fellowship in the American Academy, a fellowship in the Royal College in Australia, and membership in the Australian Orthopaedic Association and the International Orthopaedic Trauma Association. Associate Professor Tetsworth’s clinical focus revolves around the comprehensive management of orthopaedic infections, segmental bone defects, high-energy trauma, limb salvage and reconstruction, deformity correction, limb lengthening, and prosthetic joint infections.
In tandem with his clinical practice, Associate Professor Tetsworth is deeply engaged in orthopaedic research, with a keen interest in infection management, infection control, limb salvage, bone defect reconstruction, biomarker development for infection, bone growth hormone delivery, and the use of 3D printed models for reconstructing segmental bone defects.
His professional journey has been profoundly shaped by training under esteemed mentors like Professor Dror Paley and Dr George Cierny in the United States. This formative training has equipped him with a high level of expertise in addressing complex orthopaedic conditions, particularly those related to bone loss and infection. Having practiced in the United States, notably at the University of Maryland and the shock trauma hospital in Baltimore, Associate Professor Tetsworth relocated to Australia in 2000 and has since played a pivotal role in advancing orthopaedic surgery at the Royal Brisbane Hospital.
Associate Professor Tetsworth’s unwavering commitment to advancing orthopaedic knowledge and his exceptional proficiency in managing challenging orthopaedic conditions have earned him widespread recognition within the field.
In this Australian Health Journal interview, Assoc Professor Tetsworth talks about his clinical and research career journey and gives advice for those in medicine considering a career in orthopaedic surgery,
Assoc Prof Tetsworth concludes with a discussion on ways infection control is handled in preoperative, intraoperative and post operatively for orthopaedic surgeries.
He discusses the techniques started in the 19th century with understanding of hand hygiene, surgical instruments being sterilised and discovery of antibiotics in the 20th century, to present day practises of patient modifiable factors such as prescreening patients, lifestyle adjustments such as BMI or weight management, checking HbA1c levels for those who are diabetic and use of triclosan coated sutures in wound dressing in the early post operative period.
-
Emerging researcher appointed to James Packer Chair in Mood Disorders at UNSW
The UNSW Discipline of Psychiatry and Mental Health is widely renowned as the pre-eminent psychiatry research department in the country and one of the leading university psychiatry research groups internationally. In 2023 it celebrated 60 Years of Psychiatry & Mental Health at UNSW Sydney.
Australian Health Journal spoke with Professor Kimberlie Dean, Head of the Discipline of Psychiatry and Mental Health at UNSW Sydney, about the recent appointment of mental health disorders expert and clinician researcher Dr Aswin Ratheesh to lead the James Packer Chair in Mood Disorders at UNSW Sydney. -
Recognising service in health regulation
In April 2023, Professor John Skerritt retired from his position of Deputy Secretary Health Products Regulation Group, a role he has been in since 2012. During his time at the TGA he had line responsibility for over 1200 staff involved in the regulation of therapeutic goods, regulation of gene technology and industrial chemicals and control of drug import, export and production.
At this year’s ARCS 2023 Conference, ARCS Australia CEO Dr Shanny Dyer paid tribute to Professor Skerritt and his service to the Australian health industry. She led a tribute with fellow industry heads, Elizabeth de Somer, CEO, Medicines Australia, Anne Harris, Managing Director, Pfizer Australia & New Zealand, Deon Schoombie, CEO, Consumer Healthcare Products Australia, Ian Burgess, CEO, Medical Technology Association of Australia and Arthur Brandwood, President ARCS Australia.
-
Clinical research integrates with GP and Pharmacist workflows to supplement practice revenue
Clinical trials are crucial to the development of evidence-based preventative medicines. In addition, participation in clinical trials can also provide patients with opportunities to access new treatments.
“Clinical trials are at the heart of medical advances which look into new ways to treat, prevent, or detect disease. Volunteers often do so to help contribute to advancing scientific research, knowing that they are participating in the hope of helping future generations,” said Charlotte Bradshaw, CEO and Founder to Evrima Technologies.
